Precise Biometrics (PREC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
15 Aug, 2025Executive summary
Strong demand and stable performance continued despite geopolitical shifts and a weaker USD, with commercial progress in national ID programs and new customer projects in India expected to drive growth in 2025.
Expansion in visitor management systems and a rebranding initiative were key developments during the quarter.
The company remains cost-conscious, achieving efficiency improvements and strengthening sales capabilities with minimal cost increases.
Financial highlights
Q2 net sales were SEK 20.8 million, up 1.0% year-over-year; interim period net sales were SEK 40.8 million, down 3.5% year-over-year.
Q2 EBITDA was SEK -0.5 million; adjusted for currency and revenue allocation effects, EBITDA was SEK 1.4 million.
Q2 operating loss (EBIT) was SEK -5.7 million; interim EBIT was SEK -12.8 million.
Q2 earnings per share were SEK -0.07; interim period EPS was SEK -0.17.
Cash flow from operating activities was SEK 1.3 million in Q2 and SEK 3.4 million for the interim period.
Annual Recurring Revenue (ARR) at period end was SEK 18.2 million, impacted by a SEK 0.8 million loss due to a customer bankruptcy.
Outlook and guidance
Positive outlook for full year 2025, with strong indications for solid growth driven by new offerings in national ID, palm recognition, and on-premise access systems.
Market demand for biometric and cybersecurity solutions is increasing, though business discussions are taking longer due to the market environment.
Latest events from Precise Biometrics
- Merger forms a global biometrics leader, targeting SEK 45 million in annual synergies by 2027.PREC
M&A announcement23 Mar 2026 - Positive EBITDA and cash flow achieved despite revenue decline and postponed customer volumes.PREC
Q4 202512 Feb 2026 - Positive EBITDA and stable ARR amid lower sales, with strong demand for biometric solutions.PREC
Q3 202514 Nov 2025 - Q3 delivered strong growth, positive EBIT, and record margins, with robust outlook ahead.PREC
Q3 202413 Jun 2025 - Net sales and EBITDA rose, with ARR and new projects supporting growth outlook.PREC
Q2 202413 Jun 2025 - Fifth straight quarter of growth and positive EBITDA, with strong outlook for 2025.PREC
Q4 20245 Jun 2025 - Net sales fell 7.7% in Q1 2025, but growth prospects remain strong for the year.PREC
Q1 20255 Jun 2025